Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stiripentol PK in Renal Impairment
NCT05735951Phase 1Completed
- Sponsor
- Biocodex
- Start
- Jul 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of stiripentol in Dravet syndrome (4 arms), sponsored by Biocodex. Primary endpoints: Area under the plasma concentration versus time curve at Day 15 and Peak Plasma Concentration at Day 15. Started Jul 2023; status: completed.
02
Drugs
stiripentol
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT05735951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05735951.